Citadel Advisors’s Nexalin Technology NXL Stock Holding History

Citadel Advisors’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,907	Closed	-$17.2K	–	13839
2025 Q4	$17.2K	Buy	+30,907	New	+$34.7K	﹤0.01%	12371
2025 Q3	–	Sell	-37,289	Closed	-$38K	–	13702
2025 Q2	$38K	Buy	+37,289	New	+$52.4K	﹤0.01%	11899
2024 Q4	–	Sell	-58,185	Closed	-$38.9K	–	15116
2024 Q3	$38.9K	Buy	+58,185	New	+$60K	﹤0.01%	12169
2023 Q4	–	Sell	-15,048	Closed	-$6.67K	–	14936
2023 Q3	$6.67K	Buy	+15,048	New	+$9.42K	﹤0.01%	13307
2022 Q4	–	Sell	-15,481	Closed	-$17K	–	15272
2022 Q3	$17K	Buy	+15,481	New	+$21.2K	﹤0.01%	12132

Other funds holding NXL

PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's NXL Position: Q1 2026 in Review

Citadel Advisors sold out of Nexalin Technology (NXL) in Q1 2026, closing a stake of 30,907 shares — an estimated $17.2K sold.

Citadel Advisors first reported a position in NXL in Q3 2022 and held it in 5 quarters. The position peaked at $38.9K in Q3 2024. 23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

Citadel Advisors reported no remaining Nexalin Technology position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 30,907 Nexalin Technology shares in Q1 2026, an estimated $17.2K.
Citadel Advisors first reported a position in Nexalin Technology in Q3 2022 and held it in 5 quarters.
Citadel Advisors's Nexalin Technology position peaked at $38.9K in Q3 2024.
23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.